Matthias Hornberger - Profile and Investment Details

Investor Profile

Matthias Hornberger is a Venture Capital, Private Equity Firm based in Karlsruhe, Baden-Württemberg, Germany with a diverse investment portfolio that includes companies such as AgeX Therapeutics, Pactas GmbH, Oisin Biotechnologies, Advertory, Prescreen, turn.bio, Staffbase, Babbel, Hipaway, shyftplan, Elastrin Therapeutics, MOQO, Ichor Therapeutics, Mambu, FoxBio, Underdog Pharmaceuticals, Lysoclear, CellAge, Hojoki, Cellvie, tamyca, Antoxerene, Elevian, MegaZebra, MAIA Biotech, Suitepad, LIfT BioSciences. Over time, Matthias Hornberger has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Matthias Hornberger is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, HR Tech, Android, Life Science, Information Technology (IT), Biotech, Software, Healthcare, Biotechnology, Business Information Systems, Productivity Software, Medical, Germany-founded, SaaS, Therapeutics, Media and Entertainment, Pharmaceuticals, Collaboration, Biopharma may find it worthwhile to explore potential connections with Matthias Hornberger, as their portfolio suggests a familiarity and interest in this area.

Understanding Matthias Hornberger’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.